JP2023509476A5 - - Google Patents

Info

Publication number
JP2023509476A5
JP2023509476A5 JP2022541612A JP2022541612A JP2023509476A5 JP 2023509476 A5 JP2023509476 A5 JP 2023509476A5 JP 2022541612 A JP2022541612 A JP 2022541612A JP 2022541612 A JP2022541612 A JP 2022541612A JP 2023509476 A5 JP2023509476 A5 JP 2023509476A5
Authority
JP
Japan
Prior art keywords
binding molecule
monoclonal
hours
binding
population
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022541612A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509476A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/012192 external-priority patent/WO2021141902A1/en
Publication of JP2023509476A publication Critical patent/JP2023509476A/ja
Publication of JP2023509476A5 publication Critical patent/JP2023509476A5/ja
Priority to JP2025268458A priority Critical patent/JP2026053486A/ja
Pending legal-status Critical Current

Links

JP2022541612A 2020-01-06 2021-01-05 高度にシアリル化された多量体結合分子 Pending JP2023509476A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025268458A JP2026053486A (ja) 2020-01-06 2025-12-19 高度にシアリル化された多量体結合分子

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062957745P 2020-01-06 2020-01-06
US62/957,745 2020-01-06
PCT/US2021/012192 WO2021141902A1 (en) 2020-01-06 2021-01-05 Highly sialylated multimeric binding molecules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025268458A Division JP2026053486A (ja) 2020-01-06 2025-12-19 高度にシアリル化された多量体結合分子

Publications (2)

Publication Number Publication Date
JP2023509476A JP2023509476A (ja) 2023-03-08
JP2023509476A5 true JP2023509476A5 (https=) 2024-01-11

Family

ID=76788256

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022541612A Pending JP2023509476A (ja) 2020-01-06 2021-01-05 高度にシアリル化された多量体結合分子
JP2025268458A Pending JP2026053486A (ja) 2020-01-06 2025-12-19 高度にシアリル化された多量体結合分子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025268458A Pending JP2026053486A (ja) 2020-01-06 2025-12-19 高度にシアリル化された多量体結合分子

Country Status (11)

Country Link
US (1) US20230073926A1 (https=)
EP (1) EP4087608A4 (https=)
JP (2) JP2023509476A (https=)
KR (1) KR20220122699A (https=)
CN (1) CN114945384A (https=)
AU (1) AU2021206168A1 (https=)
BR (1) BR112022013071A2 (https=)
CA (1) CA3162475A1 (https=)
IL (1) IL293739A (https=)
MX (1) MX2022008357A (https=)
WO (1) WO2021141902A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3560954T3 (pl) 2014-04-03 2021-12-13 Igm Biosciences, Inc. Zmodyfikowany łańcuch J
IL308212A (en) 2015-01-20 2024-01-01 Igm Biosciences Inc Tumor necrosis factor-α receptor binding molecules and their uses
WO2016154593A1 (en) 2015-03-25 2016-09-29 Igm Biosciences, Inc. Multi-valent hepatitis b virus antigen binding molecules and uses thereof
EP3355913B1 (en) 2015-09-30 2024-10-30 IGM Biosciences, Inc. Binding molecules with modified j-chain
EP3356401B1 (en) 2015-09-30 2020-06-24 IGM Biosciences, Inc. Binding molecules with modified j-chain
WO2024138072A1 (en) * 2022-12-22 2024-06-27 Igm Biosciences, Inc. Methods of treating autoimmune disorders using multimeric anti-cd38/anti-cd3 antibodies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2368267T3 (es) * 2006-05-24 2011-11-15 Universite De Provence (Aix-Marseille 1) Preparación y utilizaciones de las secuencias génicas codificantes de las glucosiltransferasas quiméricas con actividad de glucosilación optimizada.
US8067339B2 (en) * 2008-07-09 2011-11-29 Merck Sharp & Dohme Corp. Surface display of whole antibodies in eukaryotes
JP6238958B2 (ja) * 2012-04-05 2017-11-29 ゴットフリート・ヒムラー 分泌型免疫グロブリン複合体
US9663581B2 (en) * 2012-04-25 2017-05-30 Momenta Pharmaceuticals, Inc. Modified glycoproteins
KR101755430B1 (ko) * 2014-09-25 2017-07-27 한국생명공학연구원 개선된 효율을 갖는 시알산전달효소를 이용한 당단백질의 당사슬에 시알산을 부가하는 방법
WO2016102436A1 (en) * 2014-12-22 2016-06-30 F. Hoffmann-La Roche Ag Cmp-dependent sialidase activity
EP3355913B1 (en) * 2015-09-30 2024-10-30 IGM Biosciences, Inc. Binding molecules with modified j-chain
MX2020009069A (es) * 2018-03-01 2020-10-08 Igm Biosciences Inc Mutaciones de fc de igm y de la cadena j que afectan la semivida de igm en suero.

Similar Documents

Publication Publication Date Title
JP2023509476A5 (https=)
US11713453B2 (en) Enzymes for trimming of glycoproteins
JP7138046B2 (ja) 二特異性抗体基幹
JP2023509476A (ja) 高度にシアリル化された多量体結合分子
JP7812230B2 (ja) ポリペプチド鎖交換による抗体由来ポリペプチドの生成
JP7835691B2 (ja) 高シアル化免疫グロブリン
JP7449591B2 (ja) 抗体グリコフォームをリモデリングするための融合タンパク質
JP2022545682A5 (https=)
JP2024507693A (ja) 二重特異性抗体
JP2023526421A5 (https=)
JP7440516B2 (ja) 切断多価多量体
JP7688584B2 (ja) ポリペプチド鎖の交換により活性化される治療用多重特異性ポリペプチド
JP2022530034A (ja) 半減期が延長された活性化可能な治療用多重特異性ポリペプチド
JP5687271B2 (ja) 酵素による抗体処理方法
JP7753236B2 (ja) グリカンのシアリル化のための酵素
JP2024526356A5 (https=)
KR20190000009A (ko) 드로소필라 멜라노개스터 s2를 이용한 메르스 항원 단백질 생산방법
WO2023097604A1 (zh) 分离的多肽及其应用
KR101949009B1 (ko) 융합단백질-다당 복합체의 제조방법 및 이의 용도
WO2008064686A1 (en) Methods of separating nucleic acids and protein
JP4006511B2 (ja) Dna増幅方法、アミノ酸配列の繰り返し配列をコードする遺伝子
Okamoto Recent Advancements in the Preparation of Structurally Defined Glycoproteins
HK40062072B (zh) 通过多肽链交换产生抗体衍生的多肽
KR20030027470A (ko) 비형 간염 바이러스 프리에쓰1 항원 유래의 에피토프 태그및 이에 대한 항체를 이용한 폴리펩티드의 검출 및 정제방법